Cargando…
Impact of metabolic control on macular thickness in diabetic macular oedema
PURPOSE: To investigate the impact of metabolic control on macular thickness measured using optical coherence tomography in patients with diabetic retinopathy with or without macular oedema. METHODS: A total of 124 patients with diabetic retinopathy (n = 70 without macular oedema and n = 54 with mac...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5818022/ https://www.ncbi.nlm.nih.gov/pubmed/29212365 http://dx.doi.org/10.1177/1479164117746023 |
_version_ | 1783300961930838016 |
---|---|
author | Peng, Yi-Jie Tsai, Meng-Ju |
author_facet | Peng, Yi-Jie Tsai, Meng-Ju |
author_sort | Peng, Yi-Jie |
collection | PubMed |
description | PURPOSE: To investigate the impact of metabolic control on macular thickness measured using optical coherence tomography in patients with diabetic retinopathy with or without macular oedema. METHODS: A total of 124 patients with diabetic retinopathy (n = 70 without macular oedema and n = 54 with macular oedema) were enrolled. Optical coherence tomography parameters measured included central macular thickness and total macular volume. Metabolic factors with correlation to optical coherence tomography parameters were fasting plasma glucose, glycosylated haemoglobin, triglyceride, low-density lipoprotein and estimated glomerular filtration rate. Multiple linear regression models were used to evaluate associations between optical coherence tomography parameters and metabolic factors. RESULTS: Higher glycosylated haemoglobin values were correlated with increased central macular thickness in patients without macular oedema (R = 0.289, p = 0.015), whereas glycosylated haemoglobin values were inversely associated with central macular thickness in patients with macular oedema (R = –0.374, p = 0.005). Both were found to be statistically significant after adjusting for age, sex and diabetic retinopathy severity in addition to other metabolic factors (p = 0.009 and p = 0.002, respectively). CONCLUSION: Strict metabolic control may not be associated with better macular thickness in diabetic patients with co-existing macular oedema. |
format | Online Article Text |
id | pubmed-5818022 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | SAGE Publications |
record_format | MEDLINE/PubMed |
spelling | pubmed-58180222018-03-01 Impact of metabolic control on macular thickness in diabetic macular oedema Peng, Yi-Jie Tsai, Meng-Ju Diab Vasc Dis Res Brief Reports PURPOSE: To investigate the impact of metabolic control on macular thickness measured using optical coherence tomography in patients with diabetic retinopathy with or without macular oedema. METHODS: A total of 124 patients with diabetic retinopathy (n = 70 without macular oedema and n = 54 with macular oedema) were enrolled. Optical coherence tomography parameters measured included central macular thickness and total macular volume. Metabolic factors with correlation to optical coherence tomography parameters were fasting plasma glucose, glycosylated haemoglobin, triglyceride, low-density lipoprotein and estimated glomerular filtration rate. Multiple linear regression models were used to evaluate associations between optical coherence tomography parameters and metabolic factors. RESULTS: Higher glycosylated haemoglobin values were correlated with increased central macular thickness in patients without macular oedema (R = 0.289, p = 0.015), whereas glycosylated haemoglobin values were inversely associated with central macular thickness in patients with macular oedema (R = –0.374, p = 0.005). Both were found to be statistically significant after adjusting for age, sex and diabetic retinopathy severity in addition to other metabolic factors (p = 0.009 and p = 0.002, respectively). CONCLUSION: Strict metabolic control may not be associated with better macular thickness in diabetic patients with co-existing macular oedema. SAGE Publications 2017-12-07 2018-03 /pmc/articles/PMC5818022/ /pubmed/29212365 http://dx.doi.org/10.1177/1479164117746023 Text en © The Author(s) 2017 http://creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (http://www.creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage). |
spellingShingle | Brief Reports Peng, Yi-Jie Tsai, Meng-Ju Impact of metabolic control on macular thickness in diabetic macular oedema |
title | Impact of metabolic control on macular thickness in diabetic macular oedema |
title_full | Impact of metabolic control on macular thickness in diabetic macular oedema |
title_fullStr | Impact of metabolic control on macular thickness in diabetic macular oedema |
title_full_unstemmed | Impact of metabolic control on macular thickness in diabetic macular oedema |
title_short | Impact of metabolic control on macular thickness in diabetic macular oedema |
title_sort | impact of metabolic control on macular thickness in diabetic macular oedema |
topic | Brief Reports |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5818022/ https://www.ncbi.nlm.nih.gov/pubmed/29212365 http://dx.doi.org/10.1177/1479164117746023 |
work_keys_str_mv | AT pengyijie impactofmetaboliccontrolonmacularthicknessindiabeticmacularoedema AT tsaimengju impactofmetaboliccontrolonmacularthicknessindiabeticmacularoedema |